SSA
ORGO icon

Schonfeld Strategic Advisors’s Organogenesis Holdings ORGO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,000
Closed -$56.4K – 2152
2023
Q2 		$56.4K Buy
+17,000
New +$50.2K ﹤0.01% 1801
2022
Q2 		– Sell
-78,316
Closed -$597K – 2873
2022
Q1 		$597K Buy
+78,316
New +$606K 0.01% 1260
2021
Q1 		– Sell
-137,700
Closed -$1.04M – 2042
2020
Q4 		$1.04M Buy
+137,700
New +$654K 0.01% 802

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schonfeld Strategic Advisors's ORGO Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 17,000 shares — an estimated $56.4K sold.

Schonfeld Strategic Advisors first reported a position in ORGO in Q4 2020 and held it in 3 quarters. The position peaked at $1.04M in Q4 2020. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

  • Schonfeld Strategic Advisors reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,000 Organogenesis Holdings shares in Q3 2023, an estimated $56.4K.
  • Schonfeld Strategic Advisors first reported a position in Organogenesis Holdings in Q4 2020 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Organogenesis Holdings position peaked at $1.04M in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.